Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers

Billy J. Gardner, A. Marm Kilpatrick
doi: https://doi.org/10.1101/2021.12.10.21267594

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted December 12, 2021.
Download PDF
Data/Code
Email
Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers
Billy J. Gardner, A. Marm Kilpatrick
medRxiv 2021.12.10.21267594; doi: https://doi.org/10.1101/2021.12.10.21267594
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area